openPR Logo
Press release

Anthelmintic Drugs Market: Steady Growth Driven by Rising Parasitic Infections to Reach $3.7 Billion by 2031 | TMR Analysis

03-07-2025 10:08 AM CET | Health & Medicine

Press release from: Transparency Market Research

Anthelmintic Drugs

Anthelmintic Drugs

The Anthelmintic Drugs Market is a crucial segment within the pharmaceutical industry, driven by the increasing prevalence of parasitic infections in humans and animals. Anthelmintic drugs are used to treat infections caused by parasitic worms, including roundworms, tapeworms, and flukes. With the growing burden of parasitic diseases, rising awareness about deworming, and advancements in drug formulations, the market is poised for steady growth.

Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=50688

Market Overview

The global anthelmintic drugs market was valued at $2.6 billion in 2022 and is projected to grow at a CAGR of 3.9%, reaching $3.7 billion by 2031. This growth is driven by the rising prevalence of parasitic infections, increasing demand for veterinary anthelmintics, and growing awareness about the importance of deworming.

Top Manufacturers:

Novartis AG
Zoetis, Inc.
Amneal Pharmaceuticals, Inc.
Cipla Inc.
Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
Sun Pharmaceutical Industries Ltd.
GlaxoSmithKline plc
Bayer AG
Merck & Co. Inc. (Intervet Inc.)
Boehringer Ingelheim International GmbH

Key Growth Drivers

1. Rising Prevalence of Parasitic Infections

The increasing incidence of parasitic infections, particularly in developing regions, is driving the demand for anthelmintic drugs.

2. Growing Livestock Industry

The expansion of the livestock industry, driven by rising demand for animal-derived products, is boosting the need for effective parasitic control measures.

3. Increasing Awareness About Deworming

Growing awareness about the importance of deworming in humans and animals is driving the adoption of anthelmintic drugs.

4. Advancements in Drug Formulations

Innovations in drug formulations, such as extended-release and combination therapies, are enhancing the efficacy and safety of anthelmintic drugs.

Challenges

1. Resistance to Anthelmintic Drugs

The emergence of drug-resistant parasites poses a challenge to the effectiveness of anthelmintic drugs.

2. High Costs of Advanced Formulations

The costs associated with advanced drug formulations can limit accessibility, particularly in low-income regions.

3. Regulatory Hurdles

Stringent regulations for drug approvals can delay market entry and increase development costs.

Recent Trends and Developments

1. Launch of Combination Therapies

Company: Zoetis
Zoetis introduced combination anthelmintic therapies for livestock, offering improved efficacy and convenience.

2. Expansion in Emerging Markets

Company: Bayer
Bayer expanded its distribution network for anthelmintic drugs in Asia-Pacific and Africa, increasing market penetration.

3. Focus on Pediatric Deworming

Organization: World Health Organization (WHO)
The WHO launched initiatives to promote pediatric deworming in endemic regions, boosting the demand for anthelmintic drugs.

4. Rising Adoption of Digital Tools

Company: Merck Animal Health
Merck integrated digital tools to track the efficacy of its anthelmintic products, improving customer engagement and outcomes.

Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=50688

Future Outlook

The anthelmintic drugs market is expected to witness steady growth, driven by advancements in drug formulations, increasing awareness about deworming, and the rising prevalence of parasitic infections. Key opportunities include:

Development of cost-effective and easy-to-administer formulations.

Expansion into emerging markets with growing healthcare access.

Increased focus on combating drug resistance through innovative therapies.

Key Market Segments

Drug Class

Benzimidazole
Piperazine
Others

Route of Administration

Oral
Injectable

Application

Human
Parenchymal Neurocysticercosis
Gastrointestinal Infections
Animal

Target Pathogen

Ascaris Lumbricoides (Roundworm)
Trichuris Trichiura (Whipworm)
Enterobius Vermicularis (Pinworm)
Ancylostoma Duodenale (Hookworm)
Others

Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Veterinary Pharmacies
Veterinary Hospitals & Clinics

By Region

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Explore Latest Research Reports by Transparency Market Research:

Antiplatelet Drugs Market: https://www.globenewswire.com/news-release/2023/03/20/2630866/0/en/Antiplatelet-Drugs-Market-to-Hit-USD-4-1-Bn-by-2031-Due-to-the-Increase-in-Prevalence-of-Cardiovascular-Diseases-Latest-Study-by-TMR.html

Pharmaceutical Intermediates Market: https://www.globenewswire.com/news-release/2023/08/29/2733119/32656/en/Pharmaceutical-Intermediates-Market-Predicted-to-Reach-USD-53-4-billion-by-2031-Expanding-at-a-CAGR-of-6-Says-Transparency-Market-Research.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anthelmintic Drugs Market: Steady Growth Driven by Rising Parasitic Infections to Reach $3.7 Billion by 2031 | TMR Analysis here

News-ID: 3903825 • Views:

More Releases from Transparency Market Research

Dengue Testing Market to Reach USD 939.8 Mn by 2035, Expanding at a CAGR of 4.6% - By Product & Service / By Technology / By Sample Type | Asia Pacific • North America • Europe
Dengue Testing Market to Reach USD 939.8 Mn by 2035, Expanding at a CAGR of 4.6% …
The global Dengue Testing Market was valued at US$ 573.1 Mn in 2024 and is projected to reach US$ 939.8 Mn by 2035, expanding at a compound annual growth rate (CAGR) of 4.6% from 2025 to 2035. This steady growth trajectory reflects the rising global burden of dengue fever, increasing diagnostic awareness, and continuous advancements in testing technologies. Access key findings and insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=65456 Dengue has
Global Cell Cryopreservation Market to Reach USD 104.8 Billion by 2035, Driven by Rapid Growth in Cell-Based Therapies
Global Cell Cryopreservation Market to Reach USD 104.8 Billion by 2035, Driven b …
The global Cell Cryopreservation Market is poised for extraordinary growth over the next decade, fueled by accelerating advancements in regenerative medicine, cell-based therapies, and biopharmaceutical research. According to the latest industry outlook, the market was valued at US$ 14.9 billion in 2024 and is projected to reach US$ 104.8 billion by 2035, expanding at a strong compound annual growth rate (CAGR) of 19.4% from 2025 to 2035. Cell cryopreservation has become
Global Private 5G Network Market Outlook 2035: Revenue Expected to Cross US$ 78.2 Billion at 35.2% CAGR
Global Private 5G Network Market Outlook 2035: Revenue Expected to Cross US$ 78. …
The global private 5G network market was valued at US$ 2.8 billion in 2024 and is projected to expand dramatically to US$ 78.2 billion by 2035, registering an exceptional compound annual growth rate (CAGR) of 35.2% during 2025-2035. This exponential growth trajectory reflects the accelerating shift of enterprises toward dedicated, high-performance wireless networks that offer greater control, ultra-low latency, and enhanced security compared to public networks. The scale of this growth
Automotive Rain Sensors Market Outlook 2035: Global Industry is Growing from US$ 5.2 Billion to US$ 9.4 Billion by 2035 at a 6.5% CAGR
Automotive Rain Sensors Market Outlook 2035: Global Industry is Growing from US$ …
The global automotive rain sensors market is experiencing steady growth as vehicle manufacturers increasingly integrate advanced driver assistance features to enhance safety, comfort, and driving convenience. Valued at US$ 5.2 billion in 2024, the market is projected to reach US$ 9.4 billion by 2035, expanding at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2035. This growth is supported by rising vehicle production, increasing penetration of smart

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase